iRhythm Technologies, Inc. (IRTC)
| Market Cap | 7.23B |
| Revenue (ttm) | 245.46M |
| Net Income (ttm) | -51.48M |
| Shares Out | 28.05M |
| EPS (ttm) | -1.90 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 15 |
| Last Price | $250.57 |
| Previous Close | $250.57 |
| Change ($) | 0.00 |
| Change (%) | 0.00% |
| Day's Open | 246.96 |
| Day's Range | 242.03 - 255.22 |
| Day's Volume | 235,526 |
| 52-Week Range | 57.79 - 261.17 |
Investors are heartened by the cardiac device maker's revenue growth.
These companies made millions by developing equipment for life-saving care, and enriched shareholders too.
SAN FRANCISCO, Dec. 29, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today an...
The rapid adoption of telemedicine and digital health during COVID-19 pandemic is remarkable, yet unsurprising. In the years preceding the health crisis we now find ourselves in, a paradigm sh...
SAN FRANCISCO, Dec. 14, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today an...
Investors didn't like what they saw in new Medicare guidelines.
Webcast Scheduled for December 2, 2020 at 5:30 am PT/8:30 am ET Webcast Scheduled for December 2, 2020 at 5:30 am PT/8:30 am ET
Remote cardiac monitoring service Zio XT has been evaluated and positively recommended by NICE Remote cardiac monitoring service Zio XT has been evaluated and positively recommended by NICE
Sands Capital Management recently disclosed its portfolio updates for the third quarter of 2020, which ended on Sept. 30.
SAN FRANCISCO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today ann...
Telehealth stocks have come to prominence in 2020 for obvious reasons. Read on for those that are positioned to thrive moving forward.
iRhythm to Host Webcast to Discuss Outcomes on Monday, November 16, 2020 iRhythm to Host Webcast to Discuss Outcomes on Monday, November 16, 2020
There are no silver linings to the pandemic. Nevertheless, some stocks and sectors have benefited greatly from the societal changes COVID-19 has wrought.
iRhythm Technologies, Inc. (IRTC) CEO Kevin King on Q3 2020 Results - Earnings Call Transcript
iRhythm has key differentiators that insulate the company from peers and provide additional value to the clinical setting, backed by AI software and over 30 clinical studies. Shareholders have...
SAN FRANCISCO, Oct. 22, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today ann...
For this report, we analyzed the portfolios of the 13 small-cap growth investment managers with the best 10-year performance records.
We highlight the first sports betting ETF and a digital health ETF
Company selected from over 500 applicants in first-of-its-kind Digital Health Technologies Pilot Company selected from over 500 applicants in first-of-its-kind Digital Health Technologies Pilot
SAN FRANCISCO, Sept. 01, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today...
SAN FRANCISCO, Aug. 21, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, announ...
SAN FRANCISCO, Aug. 18, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, announ...
SAN FRANCISCO, Aug. 18, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, announ...
iRhythm (IRTC) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
iRhythm Technologies, Inc. (IRTC) CEO Kevin King on Q2 2020 Results - Earnings Call Transcript
Technical analyst Jonathan Krinsky believes small-cap stocks could benefit from a rotation out of large-cap techs. Here are 10 to consider.
SAN FRANCISCO, Aug. 06, 2020 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by iRhythm Technologies, Inc. (NASDAQ: IRTC), please note that in the table of Cond...
SAN FRANCISCO, Aug. 04, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, commen...
Conference Call and Webcast Scheduled for August 4, 2020 at 1:10 pm PT/4:10 pm ET Conference Call and Webcast Scheduled for August 4, 2020 at 1:10 pm PT/4:10 pm ET
SAN FRANCISCO, Aug. 04, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, commen...
IRHYTHM TECH (IRTC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SAN FRANCISCO, July 29, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today ...
SAN FRANCISCO, July 21, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today a...
The coronavirus pandemic is changing how people access health care, and is helping give rise to the nascent industry owned by telemedicine and remote-monitoring companies. The post How The Pa...
Bullish chart patterns on the KOMP ETF and its top holdings suggest that it could be an ideal time to increase exposure to innovative tech companies.
SAN FRANCISCO, June 04, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, announ...
iRhythm Technologies, Inc. (IRTC) CEO Kevin King on Q1 2020 Results - Earnings Call Transcript
IRHYTHM TECH (IRTC) delivered earnings and revenue surprises of 40.35% and 3.49%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
IRHYTHM TECH (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SAN FRANCISCO, April 29, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today...
IRHYTHM TECH (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SAN FRANCISCO, April 23, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today...
Announces Preliminary Revenue Results for First Quarter of 2020; Withdraws 2020 Financial Guidance Announces Preliminary Revenue Results for First Quarter of 2020; Withdraws 2020 Financial Gui...
iRhythm Technologies' (IRTC) CEO Kevin King on Q4 2019 Results - Earnings Call Transcript
IRHYTHM TECH (IRTC) delivered earnings and revenue surprises of -25.00% and 0.61%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
IRHYTHM TECH (IRTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IRHYTHM TECH (IRTC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SAN FRANCISCO, Dec. 16, 2019 (GLOBE NEWSWIRE) -- iRhythm Technologies , Inc. (NASDAQ: IRTC) today announced its participation in a new, randomized, controlled study, GUARD-AF (ReducinG stro...
SAN FRANCISCO, Nov. 19, 2019 (GLOBE NEWSWIRE) -- iRhythm Technologies , Inc. (NASDAQ: IRTC) announced today that it received a standard notification letter (the “Notice”) from The Nasdaq St...
iRhythm Technologies' (IRTC) CEO Kevin King on Q3 2019 Results - Earnings Call Transcript
About IRTC
iRhythm Technologies, a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG dat... [Read more...]
| Industry Medical Instruments & Supplies | IPO Date Oct 20, 2016 |
| CEO Kevin King | Employees 997 |
| Stock Exchange NASDAQ | Ticker Symbol IRTC |
Financial Performance
In 2019, IRTC's revenue was $214.55 million, an increase of 45.68% compared to the previous year's $147.28 million. Losses were -$54.57 million, 8.32% more than in 2018.
Analyst Forecasts
According to 11 analysts, the average rating for IRTC stock is "Buy." The 12-month stock price forecast is 238.13, which is a decrease of -4.96% from the latest price.